| 2023 | Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors
| ADVANCES IN THERAPY |
| 2022 | Real-World Effectiveness, Tolerability, and Safety of Dolutegravir/Lamivudine in Korea
| VIRUSES-BASEL |
| 2022 | Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
| 2019 | Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
| 2021 | Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
| 2020 | Real-world efficacy and safety of nebivolol in Korean patients with hypertension from the BENEFIT KOREA study | JOURNAL OF HYPERTENSION |
| 2024 | Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea
| JOURNAL OF KOREAN MEDICAL SCIENCE |
| 2022 | Real-world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
| ESC HEART FAILURE |
| 2021 | Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO)
| Clinical Hypertension |
| 2021 | Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea
| TRANSLATIONAL LUNG CANCER RESEARCH |
| 2022 | Real-world experience of angiotensin receptor neprilysin inhibitor on the glucose-lowering effect
| SCIENTIFIC REPORTS |
| 2020 | Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
| CANCER RESEARCH AND TREATMENT |
| 2022 | Real-world experience of safety and effectiveness of regorafenib for treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumors, and hepatocellular carcinoma: a post-marketing surveillance study in Korea
| JOURNAL OF CANCER |
| 2023 | Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data
| TRANSLATIONAL LUNG CANCER RESEARCH |
| 2022 | Real-world global data on targeting epidermal growth factor receptor mutations in stage III non-small-cell lung cancer: the results of the KINDLE study
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
| 2023 | Real-world impact of the fixed-dose combination on improving treatment outcomes of drug-susceptible tuberculosis: a comparative study using multiyear national tuberculosis patient data
| BMJ OPEN RESPIRATORY RESEARCH |
| 2021 | Real-World Long-Term Clinical Outcomes of Ultrathin Strut Biodegradable Polymer Drug-Eluting Stents in Korean ST-Segment-Elevation Myocardial Infarction (STEMI) Patients with or without Acute Heart Failure Undergoing Primary Percutaneous Coronary Intervention
| JOURNAL OF CLINICAL MEDICINE |
| 2020 | Real-World National Colonoscopy Volume in Korea: A Nationwide Population-Based Study over 12 Years
| Gut and Liver |
| 2021 | Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2021 | Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis | CANCER COMMUNICATIONS |
